Sponsor or institution
Clinical trials and research at University Hospital Schleswig-Holstein
As of November 12, 2026, Find a Trial lists 17 clinical trials run by University Hospital Schleswig-Holstein that are recruiting, at sites in 9 countries (most in Germany (17), Denmark (1), Australia (1)). By phase: Phase 2 (2), Phase 2/3 (1), Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 9Countries
Newest trials
All recruiting trials (17)
-
Nicotinamide in specialized capsules for post-COVID syndrome (PCS)
People with post-COVID symptoms could try a daily 500 mg nicotinamide tablet that releases in the lower gut to see if it helps their recovery.
-
Tralokinumab for moderate-to-severe atopic dermatitis affecting the genital area
This trial will try tralokinumab in adults with moderate-to-severe atopic dermatitis involving the genital region to see if it improves genital symptoms and quality of life.
-
Prevention in PD: a six-month lifestyle program for PD and RBD
This study tests whether a six-month, structured lifestyle program combining exercise, Mediterranean diet, sleep guidance, and cognitive training helps people with Parkinson’s disease or REM sleep behavior disorder stick to healthier habits.
-
Oral ileum-targeted controlled-release nicotinic acid to reverse prediabetes
This trial tests whether taking a daily oral ileum-targeted controlled-release nicotinic acid pill for 26 weeks can help adults with prediabetes return to normal blood sugar and remains safe.
-
Early mirikizumab versus azathioprine for newly diagnosed moderate-to-severe ulcerative colitis
This trial will test whether starting mirikizumab right away instead of beginning with azathioprine helps people newly diagnosed with moderate-to-severe ulcerative colitis who did not respond well to mesalazine and steroids.
-
Kidney and heart prevention program after preeclampsia
This program will see if follow-up care plus a biobank can help identify and manage long-term kidney and heart risks for women who had preeclampsia, HELLP, eclampsia, or pregnancy-related kidney disease.
-
Three-fraction prostate radiosurgery for localized prostate cancer
This trial will test whether giving prostate radiosurgery in three high-dose sessions is safe and causes fewer late urinary and bowel side effects for men with localized, low- to intermediate-risk prostate cancer.
-
Evaluating a new oral treatment for ulcerative colitis
This study is testing a new oral treatment for people with mild to moderate ulcerative colitis to see if it can help reduce inflammation and improve gut health.
-
Using a reminder app to improve skin care for breast cancer patients during radiation therapy
This study tests if a reminder app can help breast cancer patients take better care of their skin during radiation therapy and reduce skin problems.
-
Effects of sugar on metabolism and symptoms in Parkinson's patients
This study tests how eating sugar affects insulin and symptoms in people with Parkinson's disease to see if it has any impact on their condition.
-
Understanding the factors influencing chronic inflammatory skin diseases
This study is trying to understand what causes different types of chronic skin conditions, like eczema and psoriasis, to behave differently in patients over time.
-
Screening for early signs of Parkinson's Disease
This study is trying to find early signs of Parkinson's Disease in people who might be at higher risk and will follow them for five years to learn more about how the disease develops.
-
Longterm effects of COVID-19 on health and quality of life
This study is trying to see how COVID-19 affects people's health and quality of life in the long run after they've been infected with the virus.
-
Video-based training for managing writer's cramp
This study is testing a year-long video training program to see if it can help people with writer's cramp improve their writing skills.
-
New treatment options for children and adolescents with acute lymphoblastic leukemia
This study is testing new treatment options for children and teens with acute lymphoblastic leukemia to see if combining standard chemotherapy with other therapies can help them live longer without their cancer coming back.
-
Investigating disease progression and treatment responses in atopic dermatitis and psoriasis
This study is looking at how atopic dermatitis and psoriasis change over time and how different treatments work for people with these skin conditions.
-
Exploring molecular profiles in inflammatory skin diseases
This study is trying to see how different biological factors in the skin affect psoriasis and atopic dermatitis, and how treatments can help manage these conditions better.
Quick answers
How many clinical trials run by University Hospital Schleswig-Holstein are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 9 countries. The most sites are in Germany (17 trials), Denmark (1 trial), Australia (1 trial), Austria (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 2/3: 1, Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.